Idenix Pharmaceuticals News
Most Popular Idenix Pharmaceuticals Story
GSK licenses Idenix HIV drug for $450M
GSK has inked a $450 million deal for Idenix Pharmaceutical's experimental HIV/AIDS drug, IDX899. Idenix gets a $34 million up-front payment; half was cash and the rest came from a purchase of Idenix... Read more...
Latest Headlines
- February 6, 2009
- February 7, 2008
- September 28, 2007
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges
